Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Fida Biosystems ApS
APS
Active
CVR 34687870
Generatorvej 8D, 2860
Søborg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
22 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Fida Biosystems ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
19M
14M
9M
5M
0M
2021: 9M
9M
2021
2022: 11M (+22% vs 2021)
11M
+22%
2022
2023: 9M (-18% vs 2022)
9M
-18%
2023
2024: 4M (-56% vs 2023)
4M
-56%
2024
2025: 15M (+275% vs 2024)
15M
+275%
2025
EBITDA
DKK millions
9M
1M
-7M
-14M
-22M
2021: 3M
3M
2021
2022: -1M (-133% vs 2021)
-1M
-133%
2022
2023: -9M (-800% vs 2022)
-9M
-800%
2023
2024: -16M (-78% vs 2023)
-16M
-78%
2024
2025: -11M (+31% vs 2024)
-11M
+31%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
15.443
4.022
8.694
10.928
8.908
Staff expenses
-26.936
-20.165
-17.674
-11.865
-6.212
EBITDA
-11.494
-16.143
-8.980
-937
2.697
Depreciation & amort.
-4.191
-4.269
-4.703
-3.117
-851
EBIT
-15.685
-20.412
-13.683
-4.054
1.846
Net financials
-836
-295
-244
524
-176
Profit before tax
-16.521
-20.707
-13.927
-3.530
1.670
Tax
-2.700
-1.000
-966
-947
-257
Net profit
-13.821
-19.707
-12.961
-2.583
1.926
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
73.567
50.284
38.793
41.760
29.718
Equity
61.191
37.275
21.123
27.083
16.666
Long-term debt
3.621
4.422
5.164
288
288
Short-term debt
8.755
8.587
12.507
14.389
12.764
Total debt
12.376
13.009
17.671
14.677
13.052
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-74,4 %
This company
2021
2025
Equity ratio
83,2 %
This company
38,2 %
Market median
This company
Market median
118% above market
2021
2025
Return on equity
-22,6 %
This company
18,4 %
Market median
This company
Market median
223% below market
2021
2025
Net profit margin (of gross profit)
-89,5 %
This company
2021
2025
Asset turnover (of gross profit)
0,21×
This company
2021
2025
Debt / equity
0,20×
This company
0,62×
Market median
This company
Market median
68% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Fida Biosystems ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
